138 results
424B3
KBLB
Kraig Biocraft Laboratories, Inc
11 Sep 23
Prospectus supplement
4:30pm
with unconsolidated entities or other persons, also known as “special purpose entities” (SPEs).
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS … financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting
POS AM
KBLB
Kraig Biocraft Laboratories, Inc
1 Sep 23
Prospectus update (post-effective amendment)
4:30pm
as “special purpose entities” (SPEs).
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
DIRECTORS … in the registration statement;
(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective
POS AM
3dppnkd
14 Apr 23
Prospectus update (post-effective amendment)
4:59pm
424B3
5m6he62kpaubjxj2uqc1
19 Apr 22
Prospectus supplement
5:13pm
8-K
EX-10.3
jcezc9 q5jwvwkb9r
20 Jan 22
Kraig Biocraft Laboratories Closes Additional Funding Agreement
5:26pm